Notable 52-Week Highs and Lows of the Day 04/21: (SIRI) (UNH) (BIIB) High; (TEVA) (ZSTN) (AMR) Low

FREE Breaking News Alerts from StreetInsider.com!

Overall Analyst Rating:
NEUTRAL ( Down

This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today.

52-Week High:

SIRIUS XM Radio Inc. (Nasdaq: SIRI) high of $1.93. Sirius may just be getting above the $1.86 - $1.88 resistance level that its seen since the start of 2011. Volume on the move is a little bit ahead of average, possibly indicating a break out on the stock. Shares moved 3.2 percent to the high today.
Unitedhealth Group, Inc. (NYSE: UNH) high of $48.79. United Health is seeing a spike today following solid first-quarter results and guidance from the Company. United Health reported EPS of $1.22 on revs of $25.4 billion, versus consensus EPS of $0.89 and revs of $24.93 billion. Looking ahead, United Health sees FY11 EPS of $3.95 - $4.05 and revs of $101 billion, topping consensus views calling for EPS of $3.78 and revs of $100.51 billion. Shares moved 10.3 percent higher today.
Biogen Idec Inc. (Nasdaq: BIIB) high of $106.99. Biogen is ripping today, following reports from CEO George A. Scangos, Ph.D., that its BG-12 multiple sclerosis pill returned strong results in a define trial. The pill reduced 2-year relapses by 49 percent and reduced disability progression by 38 percent. Biogen shares up over 23 percent to the high.
SLM Corporation (NYSE: SLM) high of $16.86. After the market closed yesterday, reported first quarter EPS of $0.48, which was eight cents better than the analyst estimate of $0.40. SLM also announced a $300 million stock buyback, and reinstated a quarterly dividend at $0.10 per outstanding common share. The stock is up 16.6 percent today.

52-Week Low:

Teva Pharmaceutical Industries Limited (Nasdaq: TEVA) low of $45.68. Teva Pharma fell following reports from Biogen. The Company also issued a statement today, saying in part: "It is important to note that as a general rule, results obtained in clinical trials in multiple sclerosis (MS) cannot be compared, unless agents are tested in a head-to-head manner in the same trial. Methodological differences between the DEFINE and ALLEGRO studies, mainly in the definition of the key endpoints, only underscore the inability to compare these two important clinical trials."
ZST Digital Networks, Inc. (Nasdaq: ZSTN) low of $2.51. ZST is selling today, following a negative article claiming that the Company is a stock fraud. Shares down over 42 percent today, to the new low.
AMR Corp. (NYSE: AMR) low of $5.50. AMR making another commodities move today, as crude is once again pushing north of $110 per barrel. Yesterday, AMR reported a loss of $1.21 per share on revenues of $5.53 billion, narrower than the consensus calling for a loss of $1.32 and revs of $5.5 billion. Barclays is giving the stock a little love today though, maintaining an Overweight, but seeing some tough spots ahead.